Has Inger Rosner, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,744 in general payments to Inger Rosner, MD across 6 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Inger Rosner, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Inger Rosner, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Inger Rosner, MD

Urology · Washington, DCNPI 1326263427

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $3,482 of the $3,744 with a category attached, or 93.0%. Ferring Pharmaceuticals Inc. accounts for 97.1% of it on its own, with 3 other manufacturers making up the rest. 2025 is the largest year on record at $3,697, more than ten times the $23 reported in 2021.

$3,744in general payments, 2019–2025

Across 6 payments — averaging $623.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Ferring Pharmaceuticals Inc.$4K
Angiodynamics, Inc.$62
Bioprotect Medical, Inc.$24
E.r. Squibb & Sons, L.L.C.$23

$61,316in research payments, 2019–2025

Across 14 payments — averaging $4379.72 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Dendreon Pharmaceuticals LLC$42K
Clovis Oncology, Inc.$19K

What the payments were for

Consulting fees$3,48293%
Food & beverage$2627%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Ferring Pharmaceuticals Inc.	2	$3,635
Angiodynamics, Inc.	2	$62
Bioprotect Medical, Inc.	1	$24
E.r. Squibb & Sons, L.L.C.	1	$23

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ADSTILADRIN$3,635

How this compares

$3,744 in reported general payments places this provider in the 65th percentile of 47 urology providers in District of Columbia.

See all urology providers in District of Columbia →

Medicare billing

Part B allowed, 2024

$250,701

Medicare patients

496

Services billed

1,366

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
MyrbetriqMirabegron	23	$26,222
Tamsulosin Hcl	159	$2,551
Finasteride	81	$820
Tolterodine Tartrate ErTolterodine Tartrate	14	$789
Oxybutynin Chloride	16	$331
Alfuzosin Hcl ErAlfuzosin Hcl	19	$175
Cefdinir	19	$169

Paid to pharmacies, not to this prescriber.

Other urology in Washington

Armine SmithWashington$58K
Nathan ShawWashington$54K
Lambros StamatakisWashington$39K
Patrick MufarrijWashington$31K
Ryan HankinsWashington$29K
Adam MetwalliWashington$27K
Michael WhalenWashington$17K
Pamela ColemanWashington$14K
Leslie DeaneWashington$13K
Jason EngelWashington$12K

See the full list for District of Columbia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →